Literature DB >> 32272374

The change of prevalence and recurrence of acute otitis media in Korea.

Tae-Hun Kim1, Jae-Min Jeon1, June Choi2, Gi Jung Im3, Jae-Jun Song1, Sung-Won Chae4.   

Abstract

OBJECTIVES: Acute otitis media (AOM) is the most common infectious disease in infants and children. However, there have been few studies on the recent prevalence and trends of pediatric AOM in Korea. This study aimed to evaluate the prevalence and trends of pediatric AOM in Korea.
METHODS: The data for patients with AOM in 2012, 2015, and 2017 were extracted from the Health Insurance Review and Assessment Service's Big Database. The prevalence rate, recurrence rate, and data on gender, region, month, and medical facilities of AOM were evaluated.
RESULTS: The prevalence rate (per 1000 persons) decreased from 152.7 in 2012 to 137.4 in 2017. The recurrence rate declined from 34.0% in 2012 to 28.2% in 2015. In 2015, the recurrence rate of 0-2 years group decreased significantly. In 2017, the prevalence of AOM of 3-6 years group decreased the most. The prevalence is higher in urban areas and recurrence rate is higher in rural areas. But those are no significant difference. AOM is more common in male, mainly in winter and spring. CONCLUSIONS AND SIGNIFICANCE: The prevalence and recurrence rate of pediatric AOM in Korea are gradually decreasing. The decrease of prevalence resulted from declination in AOM recurrence of 0-2 years group in 2015 and AOM occurrence of 3-6 years group in 2017.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute otitis media; Prevalence; Recurrence

Year:  2020        PMID: 32272374     DOI: 10.1016/j.ijporl.2020.110002

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  1 in total

1.  Particular matter influences the incidence of acute otitis media in children.

Authors:  Mina Park; Jiyeon Han; Jiwon Park; Myoung-Jin Jang; Moo Kyun Park
Journal:  Sci Rep       Date:  2021-10-05       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.